gemcitabine has been researched along with Psoriasis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, C; Chen, X; Kuang, Y; Lei, L; Li, J; Liu, P; Peng, C; Tan, L; Zhu, W | 1 |
| Dianzani, C; La Cesa, A; Landi, D; Santini, D; Tonini, G; Vincenzi, B | 1 |
| Akrivakis, K; Beinert, T; Flath, B; Genvresse, I; Possinger, K; Späth-Schwalbe, E | 1 |
1 review(s) available for gemcitabine and Psoriasis
| Article | Year |
|---|---|
Dramatic improvement of psoriasis with gemcitabine monotherapy.
Topics: Adenocarcinoma; Adult; Antimetabolites, Antineoplastic; Deoxycytidine; Gemcitabine; Humans; Male; Pancreatic Neoplasms; Psoriasis; T-Lymphocytes | 2003 |
2 other study(ies) available for gemcitabine and Psoriasis
| Article | Year |
|---|---|
Targeting Myeloid-Derived Suppressor Cells Is a Novel Strategy for Anti-Psoriasis Therapy.
Topics: Adult; Animals; CD4-Positive T-Lymphocytes; Cell Differentiation; Cells, Cultured; Deoxycytidine; Female; Flow Cytometry; Gemcitabine; Humans; Male; Membrane Proteins; Mice; Mice, Inbred BALB C; Middle Aged; Myeloid-Derived Suppressor Cells; Psoriasis; Receptors, Interleukin-21; T-Lymphocytes, Regulatory; Th17 Cells; Young Adult | 2020 |
Resolution of psoriatic skin lesions after chemotherapy with gemcitabine and vinorelbine.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Deoxycytidine; Dermatologic Agents; Gemcitabine; Humans; Lung Neoplasms; Male; Psoriasis; Vinblastine; Vincristine; Vinorelbine | 2000 |